APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 31 filers reported holding APPLIED DNA SCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $9,000 | -55.0% | 40,695 | 0.0% | 0.00% | – |
Q2 2019 | $20,000 | -31.0% | 40,695 | 0.0% | 0.00% | – |
Q1 2019 | $29,000 | +81.2% | 40,695 | 0.0% | 0.00% | – |
Q4 2018 | $16,000 | -73.8% | 40,695 | 0.0% | 0.00% | – |
Q3 2018 | $61,000 | +19.6% | 40,695 | 0.0% | 0.00% | – |
Q2 2018 | $51,000 | -13.6% | 40,695 | 0.0% | 0.00% | – |
Q1 2018 | $59,000 | -9.2% | 40,695 | 0.0% | 0.00% | – |
Q4 2017 | $65,000 | -42.0% | 40,695 | +4.5% | 0.00% | – |
Q3 2017 | $112,000 | +62.3% | 38,924 | 0.0% | 0.00% | – |
Q2 2017 | $69,000 | +7.8% | 38,924 | 0.0% | 0.00% | – |
Q1 2017 | $64,000 | +1.6% | 38,924 | +14.4% | 0.00% | – |
Q4 2016 | $63,000 | -37.6% | 34,039 | +2.9% | 0.00% | – |
Q3 2016 | $101,000 | -5.6% | 33,086 | 0.0% | 0.00% | – |
Q2 2016 | $107,000 | -6.1% | 33,086 | 0.0% | 0.00% | – |
Q1 2016 | $114,000 | +6.5% | 33,086 | 0.0% | 0.00% | – |
Q4 2015 | $107,000 | +1.9% | 33,086 | +61.9% | 0.00% | – |
Q3 2015 | $105,000 | – | 20,431 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
Creative Planning | 56,234 | $172,000 | 0.00% |